Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)

SHA:688273 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	367.05	816.45	461.56	991.63	1,176	272.62
Trading Asset Securities	356.03	-	433.42	105.65	40	-
Cash & Short-Term Investments	723.07	816.45	894.98	1,097	1,216	272.62
Cash Growth	-9.54%	-8.77%	-18.44%	-9.75%	345.98%	81.97%
Accounts Receivable	37.99	27.91	17.79	11.41	26.84	10.18
Other Receivables	0.65	0.74	1.16	1.47	1.46	0.3
Receivables	38.63	28.66	18.94	12.88	28.3	10.48
Inventory	81.32	71.99	73.05	55.02	68.59	38.49
Prepaid Expenses	-	0.11	0.16	-	-	-
Other Current Assets	22.11	13.61	14.52	6.67	7.9	19.69
Total Current Assets	865.13	930.81	1,002	1,172	1,321	341.28
Property, Plant & Equipment	464.47	470.73	327.42	207.59	154.73	123.82
Long-Term Investments	128.17	100.08	98.73	79.7	0.56	0.44
Goodwill	41.23	41.23	41.9	0.91	0.91	0.91
Other Intangible Assets	44.75	49.57	55.61	31.21	18.5	7.19
Long-Term Deferred Tax Assets	21.08	17.93	9.49	9.99	6.14	6.47
Long-Term Deferred Charges	17.04	17.54	8.13	5.27	6.59	8.03
Other Long-Term Assets	30.05	1.38	3.69	27.4	3.88	0.59
Total Assets	1,612	1,629	1,547	1,534	1,512	488.74

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	76.06	14.17	17.04	9.16	12.57	13.09
Accrued Expenses	13.48	33.97	37.65	23.97	26.6	32.64
Short-Term Debt	17.92	13.1	7.01	-	-	-
Current Portion of Leases	-	3.84	2.94	6.13	1.44	2.12
Current Income Taxes Payable	5.61	1.14	0.68	3.45	9.26	5.12
Current Unearned Revenue	43.89	51.61	51.27	45.66	47.98	33.3
Other Current Liabilities	54.1	102.94	46.38	44.86	25.7	13.85
Total Current Liabilities	221.98	220.78	162.96	133.24	123.55	100.11
Long-Term Leases	6.9	9.49	0.65	2.37	7.99	4.1
Long-Term Unearned Revenue	15.72	15.78	15.94	17.75	6.03	10.44
Long-Term Deferred Tax Liabilities	2.57	3.68	5.46	5.25	4.39	1.36
Other Long-Term Liabilities	8.32	9.94	14.64	-	-	-
Total Liabilities	255.48	259.67	199.66	158.6	141.96	116.01

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	100	100	100	100.62	100	75
Additional Paid-In Capital	986.86	984.66	984.54	999.45	982.7	92.55
Retained Earnings	301.9	314.07	279.91	276.8	267.48	195.95
Treasury Stock	-53.58	-53.58	-52.25	-31.09	-	-
Total Common Equity	1,335	1,345	1,312	1,346	1,350	363.5
Minority Interest	21.27	24.44	34.76	29.54	19.77	9.24
Shareholders' Equity	1,356	1,370	1,347	1,375	1,370	372.74
Total Liabilities & Equity	1,612	1,629	1,547	1,534	1,512	488.74

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	35.74	26.42	10.6	8.51	9.43	6.22
Net Cash (Debt)	687.33	790.03	884.38	1,089	1,206	266.4
Net Cash Growth	-11.86%	-10.67%	-18.77%	-9.75%	352.86%	86.98%
Net Cash Per Share	7.03	8.08	8.98	10.89	14.48	3.55
Filing Date Shares Outstanding	97.83	97.81	97.81	99.51	100	75
Total Common Shares Outstanding	97.83	97.81	97.86	100.62	100	75
Working Capital	643.16	710.03	838.7	1,039	1,197	241.17
Book Value Per Share	13.65	13.75	13.41	13.37	13.50	4.85
Tangible Book Value	1,249	1,254	1,215	1,314	1,331	355.4
Tangible Book Value Per Share	12.77	12.82	12.41	13.06	13.31	4.74
Buildings	-	348.78	112.1	112.1	112.1	112.1
Machinery	-	60.87	53.53	44.39	37.31	21.95
Construction In Progress	-	105.88	203	77.04	19.99	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error